课题基金 / 基金详情

Reversal of residue-specific ADP-ribosylations by ADP-ribosyl-acceptor hydrolases

Reversal of residue-specific ADP-ribosylations by ADP-ribosyl-acceptor hydrolases
ADP-核糖基受体水解酶逆转残基特异性 ADP-核糖基化
批准号:
10794697
负责人:
In-Kwon Kim
金额:
$4.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2025-03-01

项目摘要

项目成果

In-Kwon Kim的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Residue-specific, reversible protein ADP-ribosylations regulate a broad range of biological processes, including DNA damage responses, gene expression, and cell death. Therefore, homeostasis of cellular ADP- ribosylations is essential for maintaining genomic integrity. ADP-ribosyl-acceptor hydrolases (ARHs) are a family of metalloenzymes that regulate site-specific ADP-ribosylations. ARH3 specifically reverses poly(ADP- ribose) and mono-ADP-ribosylation at serine, a major site for modification following DNA damage, whereas ARH1 cleaves mono-ADP-ribosylation at arginine. However, there is a fundamental gap in understanding of substrate selectivity, catalysis, and function of specific activities of ARHs, which is largely due to the lack of quantitative and convenient tools and insufficient structural information on substrate-bound active forms. The objective of this application is to develop novel quantitative assays that selectively measure the reversal of residue-specific ADP-ribosylations and to elucidate the mechanism of substrate selectivity and the role of each enzymatic activity of ARH3. In support of this objective, we have developed a highly sensitive, quantitative, and convenient fluorescence-based assays that specifically monitor the reversal of poly(ADP-ribose) or serine mono-ADP-ribosylation by ARH3. We have also determined initial structures of ARH3 bound to intact substrates. Guided by these strong preliminary data, we will pursue three specific aims to test our hypothesis that the metal-coordination states and unique structural plasticity of ARHs are linked to substrate selectivity and efficient catalysis. In Aim 1, we will fully develop quantitative fluorescence-based assays that selectively monitor the reversal of residue-specific mono-ADP-ribosylations. In Aim 2, we will determine the structural bases for the specific substrate recognition and cleavage by ARHs. In Aim 3, we will identify ARH3 separation- of-function mutants to define the role of each enzymatic activity of ARH3. Our studies will provide new quantitative tools to study diverse ADP-ribosylation-metabolizing enzymes in nature and advance our understanding of the mechanisms and functions of ARHs as essential processes for maintaining life.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbrc.2022.07.087
发表时间: 2022-10-15
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Pourfarjam, Yasin, Ma, Zhijun, Kim, In-Kwon]
通讯作者: Kim, In-Kwon
DOI: 10.1371/journal.pone.0254022
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者: [Kasson S, Dharmapriya N, Kim IK]
通讯作者: Kim IK
Enzymatic Coupling of a Classical Luciferase Assay for the Quantitative Monitoring of the Protein-Free ADP-ribose.
用于定量监测无蛋白质 ADP-核糖的经典荧光素酶测定的酶促偶联。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Kasson,SamuelP, Kim,In-Kwon]
通讯作者: Kim,In-Kwon
Reversal of residue-specific ADP-ribosylations by ADP-ribosyl-acceptor hydrolases
  • 批准号:
    10392422
  • 项目类别:
  • 资助金额:
    $33.43万
  • 财政年份:
    2021
  • 负责人:
    In-Kwon Kim
  • 依托单位:
Reversal of residue-specific ADP-ribosylations by ADP-ribosyl-acceptor hydrolases
  • 批准号:
    10183062
  • 项目类别:
  • 资助金额:
    $33.49万
  • 财政年份:
    2021
  • 负责人:
    In-Kwon Kim
  • 依托单位:
Reversal of residue-specific ADP-ribosylations by ADP-ribosyl-acceptor hydrolases
  • 批准号:
    10574486
  • 项目类别:
  • 资助金额:
    $34.0万
  • 财政年份:
    2021
  • 负责人:
    In-Kwon Kim
  • 依托单位:
国内基金
海外基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    辛贵忠
  • 依托单位: